<table class="naaccr-summary-table naaccr-borders">
  <tr>
    <th class="naaccr-summary-header naaccr-borders">Item #</th>
    <th class="naaccr-summary-header naaccr-borders">Length</th>
    <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
    <th class="naaccr-summary-header naaccr-borders">Year Implemented</th>
    <th class="naaccr-summary-header naaccr-borders">Version Implemented</th>
    <th class="naaccr-summary-header naaccr-borders">Year Retired</th>
    <th class="naaccr-summary-header naaccr-borders">Version Retired</th>
  </tr>
  <tr>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1192</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">NAACCR/SEER</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2025</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">25</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
  </tr>
</table>

<br/><strong>NAACCR XML</strong>: Tumor.pretextClinicalStaging<br/><br/>

<div class='content chap10-para-head'><strong>Description</strong></div>
<div class='content chap10-para'>
<p>PRETEXT stands for PRE-Treatment Extent of tumor. This field describes the extent of involvement within the four lobes of the liver at time of a pediatric liver tumor diagnosis. It is based off clinical imaging and was originally designed to standardize imaging evaluation and risk stratification of hepatoblastoma before neoadjuvant chemotherapy or tumor resection.</p>

</div>

<div class='content chap10-para-head'><strong>Rationale</strong></div>
<div class='content chap10-para'>
<p>After initially being created by the International Childhood Liver Tumours Strategy Group (SIOPEL) in 1990, PRETEXT was introduced for use within the United States in 2014 by the Childrenâ€™s Oncology Group (COG) once radiographic imaging became more sophisticated and exploratory surgery at diagnosis was no longer advisable. It is used as a central component of risk stratification schemes that define treatment of hepatoblastoma.</p>

</div>


<div class='content chap10-para'>
<p><strong>Source documents:</strong> imaging</p>

</div>

<div class='content chap10-para'><strong>Codes</strong></div>
<table>
        <tr class='code-row'><td class='code-nbr'>1</td><td class='code-desc'>One section involved; three adjoining sections are tumor free

Stage I, Pretext 1</td></tr>
        <tr class='code-row'><td class='code-nbr'>2</td><td class='code-desc'>One or two sections involved; two adjoining sections are tumor free

Stage 2, Pretext 2</td></tr>
        <tr class='code-row'><td class='code-nbr'>3</td><td class='code-desc'>Two or three sections involved; one adjoining section is tumor free

Stage 3, Pretext 3</td></tr>
        <tr class='code-row'><td class='code-nbr'>4</td><td class='code-desc'>Four sections involved

Stage 4, Pretext 4</td></tr>
        <tr class='code-row'><td class='code-nbr'>8</td><td class='code-desc'>Not applicable: Information not collected for this case  
(If this information is required by your standard setter, use of code 8 may result in an edit error.)</td></tr>
        <tr class='code-row'><td class='code-nbr'>9</td><td class='code-desc'>Not documented in medical record

Cannot be determined by pathologist

PRETEXT not assessed or unknown if assessed</td></tr>
</table>

<div class='content chap10-para'>
<p><strong>Note 1: Effective years</strong></p>
<ul>
<li>This SSDI is effective for diagnosis years 2024+</li>
<li>For cases diagnosed 2018-2023, this SSDI must be blank</li>
</ul>
<p><strong>Note 2: Criteria for coding</strong></p>
<ul>
<li>This SSDI is based on imaging findings only**. Do not** code any findings from surgical resection in this data item. Evaluation must also be done prior to any neoadjuvant therapy</li>
</ul>
<p><strong>Note 3: Pretext Staging-Segments of the live</strong>r</p>
<ul>
<li>Caudate liver: Segment I<br />
<em><strong>Note</strong></em>: Involvement of the caudate liver is at minimum Stage 2</li>
<li>Left lateral section: Segments II &amp; III</li>
<li>Left medial section: Segments IVA &amp; IVB</li>
<li>Right anterior section: Segments V &amp; VIII</li>
<li>Right posterior section: Segments VI &amp; VII</li>
</ul>

</div>
